Stockreport

Belite Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update [Yahoo! Finance]

Belite Bio, Inc - American Depositary Shares  (BLTE) 
PDF Phase 3 trial in adolescent Stargardt 1 (STGD1) subjects, proceed without any modification; trial completion expected Q4 2025 (including a three-month follow-up period) [Read more]